Brief: Cerenis Therapeutics Holding H1 Cash Position Of EUR 13.5 Million

Abionyx Pharma SA

10/09/2018 06:06

Sept 10 (Reuters) - CERENIS THERAPEUTICS HOLDING SA
 CEREN.PA :
    * H1 OPERATING LOSS EUR 2.98 MILLION VERSUS LOSS EUR 2.89
MILLION
YEAR AGO
    * 2018 HALF-YEAR RESULTS
    * H1 SOLID CASH POSITION OF EUR 13.5 MILLION AND SIGNIFICANT
SCIENTIFIC ADVANCES
    * DID NOT GENERATE ANY REVENUE DURING THE FIRST HALF OF 2018

Source text for Eikon:  ID:nBw1h91V4a 
See also:  urn:newsml:reuters.com:*:nFWN1VW033
Further company coverage:  CEREN.PA 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))